NASDAQ:EBIO
Delisted

Eleven Biotherapeutics Fund Forecast

$3.29
+0 (+0%)
At Close: May 31, 2018
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Red day on Thursday for Eleven Biotherapeutics
(Updated on May 31, 2018)

Buy or Hold candidate since Feb 21, 2018 Gain 108.23% PDF

No changes to the price of Eleven Biotherapeutics fund on the last trading day (Thursday, 31st May 2018). During the last trading day the fund fluctuated 0% from a day low at $3.29 to a day high of $3.29. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the fund is expected to rise 216.77% during the next 3 months and, with a 90% probability hold a price between $9.18 and $13.24 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EBIO Signals & Forecast

The Eleven Biotherapeutics fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.29 and $2.67. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 30, 2018, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation

Support, Risk & Stop-loss for Eleven Biotherapeutics fund

Eleven Biotherapeutics finds support from accumulated volume at $3.22 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $3.18 (-3.32%) (This fund has low daily movements and this gives low risk. The RSI14 is 84 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (EBIO) For The Upcoming Trading Day Of Friday 1st

For the upcoming trading day on Friday, 1st we expect Eleven Biotherapeutics to open at $3.29, and during the day (based on 14 day Average True Range), to move between $3.14 and $3.44, which gives a possible trading interval of +/-$0.153 (+/-4.64%) up or down from last closing price. If Eleven Biotherapeutics takes out the full calculated possible swing range there will be an estimated 9.28% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $3.22, some $0.0700 (2.13%) from the current price of $3.29, our system finds the risk reward attractive.

Is Eleven Biotherapeutics fund A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Eleven Biotherapeutics fund to perform well in the short-term.

Current score: 3.130 Buy Candidate Unchanged

Predicted Opening Price for Eleven Biotherapeutics of Friday, June 1, 2018

Fair opening price June 1, 2018 Current price
$3.29 ( 0.00000000%) $3.29

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EBIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.29 0.00000000 %
R2 3.29 0.00000000 %
R1 3.29 0.00000000 %
Current price: 3.29
Support S1 3.29 0.00000000 %
S2 3.29 0.00000000 %
S3 3.29 0.00000000 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 3.29
Support S1 3.22 -2.13%
S2 2.79 -15.20%
S3 2.70 -17.93%

FAQ

What is the symbol for Eleven Biotherapeutics Fund and on which exchange is it traded?
The symbol for Eleven Biotherapeutics is EBIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Eleven Biotherapeutics Fund?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Eleven Biotherapeutics fund to perform well in the short-term.

How to buy Eleven Biotherapeutics Fund?
Eleven Biotherapeutics Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eleven Biotherapeutics Fund.

What's the current price of Eleven Biotherapeutics Fund?
As of the end of day on the 2018-05-31, the price of an Eleven Biotherapeutics (EBIO) share was $3.29.

What is the 52-week high and low for Eleven Biotherapeutics Fund?
The 52-week high for Eleven Biotherapeutics Fund is $3.50 and the 52-week low is $0.620.
Click to get the best stock tips daily for free!